賽爾奈微生醫股份有限公司

  • 英文名稱:CellEnvision Company Limited
  • 網址:https://www.cellenvision.biz/
  • 統一編號:90130905
  • 成立時間:2022-03-28
  • 發展階段:尚未IPO
  • 地區:新竹市東區
  • 資本額:4,350,000
  • 代表人:吳詳致

產業領域

C06再生醫療(細胞治療、基因治療、組織工程等)

簡介

CellEnvision is a Contract Development and Manufacturing Organization (CDMO) services company for medical LDT lab test and IVD (companion diagnostics) medical devices applied for Personalized Cancer Immunotherapy. We are accelerating the discovery of identification & pathogenesis in reproductive medicine and oncology by revealing the true functional biology of every patient rare cell and it’s related immuno-microenvironment by our unique Patient-Derived Organoids (PDOs) platform.

相關文章

投資雷達 查看更多